Orodispersible domperidone tablets

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/454 (2006.01) A61K 9/20 (2006.01)

Patent

CA 2645629

The present invention relates to an orodispersible tablet comprised of, by weight: a maximum of 15% of a low-dose, therapeutically active substance; from 55% to 70% of mannitol of a particle size between 30 µm and 300 µm; at least 2% of maltodextrin; from 3.5% to 8% of croscarmellose sodium; from 10% to 20% of microcrystalline cellulose; from 0.5% to 1.5% of magnesium stearate; and from 1% to 5% of flavoring (s) and sweetener (s).

La présente invention concerne un comprimé orodispersible comprenant, en poids : au maximum 15% d'une substance thérapeutiquement active à faible dose ; de 55% à 70% de mannitol ayant une taille de particule comprise entre 30 µm et 300 µm ; au moins 2% de maltodextrine ; de 3,5% à 8% de croscarmellose sodique ; de 10% à 20% de cellulose microcristalline ; de 0,5% à 1,5% de stéarate de magnésium ; et de 1% à 5% d'un ou plusieurs arômes et édulcorants.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Orodispersible domperidone tablets does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Orodispersible domperidone tablets, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Orodispersible domperidone tablets will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1594347

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.